XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive loss
Non-controlling interests
Treasury shares
Total
Beginning Balance at Dec. 31, 2017 $ 26,368 $ 14,101,689 $ 155,711,014 $ 1,230,511 $ (163,466,713) $ (1,340,533) $ (4,066,610) $ 2,195,726
Beginning Balance, shares at Dec. 31, 2017 26,367,523             (144,206)  
Net loss (2,567,833) (2,567,833)
Share-based compensation for employee and director stock awards 83,573 83,573
Common stock issued to employees and directors for stock awards $ 9 (9)
Common stock issued to employees and directors for stock awards, shares 8,500                
Foreign currency translation adjustment 135,708 135,708
Ending Balance at Mar. 31, 2018 $ 26,377 14,101,689 155,794,578 1,230,511 (166,034,546) (1,204,825) $ (4,066,610) (152,826)
Ending Balance, shares at Mar. 31, 2018 26,376,023             (144,206)  
Beginning Balance at Dec. 31, 2018 $ 26,792 14,101,689 155,931,770 1,230,511 (165,409,890) (1,498,940) 11,977 $ (4,066,610) 327,299
Beginning Balance, shares at Dec. 31, 2018 26,791,684             (144,206)  
Net loss (2,787,392) (19,941) (2,807,333)
Capital contribution from non-controlling interests of a subsidiary             56,704   56,704
Share-based compensation for employee and director stock awards 18,219   18,219
Common stock issued to investors $ 5,098 5,194,902   5,200,000
Common stock issued to investors, shares 5,098,040                
Foreign currency translation adjustment 163,687 (2,362) 161,325
Ending Balance at Mar. 31, 2019 $ 31,890 $ 14,101,689 $ 161,144,891 $ 1,230,511 $ (168,197,282) $ (1,335,253) $ 46,378 $ (4,066,610) $ 2,956,214
Ending Balance, shares at Mar. 31, 2019 31,889,724             (144,206)